IL207030B - Combinations of glucosylceramide and antibodies directed to cd3 and uses thereof - Google Patents

Combinations of glucosylceramide and antibodies directed to cd3 and uses thereof

Info

Publication number
IL207030B
IL207030B IL207030A IL20703010A IL207030B IL 207030 B IL207030 B IL 207030B IL 207030 A IL207030 A IL 207030A IL 20703010 A IL20703010 A IL 20703010A IL 207030 B IL207030 B IL 207030B
Authority
IL
Israel
Prior art keywords
glucosylceramide
combinations
antibodies directed
antibodies
directed
Prior art date
Application number
IL207030A
Other languages
Hebrew (he)
Other versions
IL207030A0 (en
Inventor
Ilan Yaron
L Weiner Howard
Original Assignee
Brigham & Womens Hospital Inc
Ilan Yaron
Hadasit Med Res Service
L Weiner Howard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2009/000072 external-priority patent/WO2009090656A2/en
Application filed by Brigham & Womens Hospital Inc, Ilan Yaron, Hadasit Med Res Service, L Weiner Howard filed Critical Brigham & Womens Hospital Inc
Priority to IL207030A priority Critical patent/IL207030B/en
Publication of IL207030A0 publication Critical patent/IL207030A0/en
Publication of IL207030B publication Critical patent/IL207030B/en

Links

IL207030A 2008-01-18 2010-07-15 Combinations of glucosylceramide and antibodies directed to cd3 and uses thereof IL207030B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL207030A IL207030B (en) 2008-01-18 2010-07-15 Combinations of glucosylceramide and antibodies directed to cd3 and uses thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2195908P 2008-01-18 2008-01-18
PCT/IL2009/000072 WO2009090656A2 (en) 2008-01-18 2009-01-18 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders
IL207030A IL207030B (en) 2008-01-18 2010-07-15 Combinations of glucosylceramide and antibodies directed to cd3 and uses thereof

Publications (2)

Publication Number Publication Date
IL207030A0 IL207030A0 (en) 2010-12-30
IL207030B true IL207030B (en) 2018-06-28

Family

ID=43570022

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207030A IL207030B (en) 2008-01-18 2010-07-15 Combinations of glucosylceramide and antibodies directed to cd3 and uses thereof

Country Status (1)

Country Link
IL (1) IL207030B (en)

Also Published As

Publication number Publication date
IL207030A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
IL248723A0 (en) Bcr-complex-specific antibodies and methods of using same
HUS1700029I1 (en) High affinity human antibodies to pcsk9
EP2347038A4 (en) Methods of humanizing and affinity-maturing antibodies
SI2373691T1 (en) Anti-fxi antibodies and methods of use
IL232276A0 (en) Antibodies to il-6 and their uses
HK1141811A1 (en) Human antibodies to human cd20 and method of using thereof cd20
EP2427479A4 (en) Antibodies and methods of use thereof
IL211623A0 (en) Anti-notch2 antibodies and methods of use
EP2367570A4 (en) Antibodies to il-6 and use thereof
IL215795A0 (en) Anti-il-17f antibodies and methods of use thereof
ZA200803237B (en) Novel synthetic fuel and method of preparation thereof
EP2246430A4 (en) Anti-adam-15 antibodies and utilization of the same
IL207030B (en) Combinations of glucosylceramide and antibodies directed to cd3 and uses thereof
GB0803958D0 (en) Novel synthetic fuel and method of preparation thereof

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees